How does emerging patent case law in the US and Europe affect precision medicine?

Mateo Aboy; Kathleen Liddell; Cristina Crespo; I. Glenn Cohen; Johnathon Liddicoat; Sara Gerke; Timo Minssen

doi:10.1038/s41587-019-0265-1

How does emerging patent case law in the US and Europe affect precision medicine?

Mateo Aboy, Kathleen Liddell, Cristina Crespo, I. Glenn Cohen, Johnathon Liddicoat, Sara Gerke, Timo Minssen

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1118-1125
Number of pages	8
Journal	Nature Biotechnology
Volume	37
Issue number	10
DOIs	https://doi.org/10.1038/s41587-019-0265-1
State	Published - Oct 1 2019

All Science Journal Classification (ASJC) codes

Biotechnology
Bioengineering
Applied Microbiology and Biotechnology
Molecular Medicine
Biomedical Engineering

Access to Document

10.1038/s41587-019-0265-1

Cite this

@article{4f23f251883f487494ee6ad0e652310a,

title = "How does emerging patent case law in the US and Europe affect precision medicine?",

author = "Mateo Aboy and Kathleen Liddell and Cristina Crespo and Cohen, {I. Glenn} and Johnathon Liddicoat and Sara Gerke and Timo Minssen",

year = "2019",

month = oct,

day = "1",

doi = "10.1038/s41587-019-0265-1",

language = "English (US)",

volume = "37",

pages = "1118--1125",

journal = "Nature Biotechnology",

issn = "1087-0156",